Ingrid Lebigot

720 total citations
8 papers, 543 citations indexed

About

Ingrid Lebigot is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Ingrid Lebigot has authored 8 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Ingrid Lebigot's work include Cancer Genomics and Diagnostics (4 papers), Erythrocyte Function and Pathophysiology (2 papers) and Cancer-related Molecular Pathways (2 papers). Ingrid Lebigot is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Erythrocyte Function and Pathophysiology (2 papers) and Cancer-related Molecular Pathways (2 papers). Ingrid Lebigot collaborates with scholars based in France, Singapore and Morocco. Ingrid Lebigot's co-authors include Xavier Sastre‐Garau, Emmanuel Barillot, Marc‐Henri Stern, Philippe Hupé, Anne Vincent‐Salomon, Jean Paul Thiery, Olivier Delattre, Martine Thioux, Patricia de Crémoux and Brigitte Sigal‐Zafrani and has published in prestigious journals such as Journal of Biological Chemistry, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ingrid Lebigot

8 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingrid Lebigot France	8	286	248	191	87	85	8	543
Véronique Haddad France	11	328 1.1×	277 1.1×	89 0.5×	47 0.5×	41 0.5×	23	550
A T'Ang United States	7	422 1.5×	375 1.5×	82 0.4×	94 1.1×	31 0.4×	14	601
Beth Blondin United States	6	453 1.6×	299 1.2×	183 1.0×	39 0.4×	48 0.6×	6	546
Michele Gabree United States	7	209 0.7×	215 0.9×	160 0.8×	244 2.8×	21 0.2×	9	524
Susan Jewell United States	10	563 2.0×	424 1.7×	245 1.3×	44 0.5×	54 0.6×	15	779
William Rickaby United Kingdom	5	454 1.6×	419 1.7×	167 0.9×	53 0.6×	51 0.6×	14	702
Virginie Caux‐Moncoutier France	11	495 1.7×	653 2.6×	234 1.2×	346 4.0×	29 0.3×	12	1.0k
Irsan Kooi Netherlands	12	231 0.8×	185 0.7×	121 0.6×	48 0.6×	24 0.3×	15	483
D. Hungermann Germany	11	265 0.9×	173 0.7×	196 1.0×	56 0.6×	14 0.2×	23	555
R.J. Salmon France	11	459 1.6×	185 0.7×	138 0.7×	28 0.3×	80 0.9×	22	789

Countries citing papers authored by Ingrid Lebigot

Since Specialization

Citations

This map shows the geographic impact of Ingrid Lebigot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Lebigot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Lebigot more than expected).

Fields of papers citing papers by Ingrid Lebigot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Lebigot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Lebigot. The network helps show where Ingrid Lebigot may publish in the future.

Co-authorship network of co-authors of Ingrid Lebigot

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Lebigot. A scholar is included among the top collaborators of Ingrid Lebigot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Lebigot. Ingrid Lebigot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Meyniel, Jean-Philippe, Paul Cottu, Charles Decraene, et al.. (2010). A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. BMC Cancer. 10(1). 222–222. 22 indexed citations

Manié, Élodie, Anne Vincent‐Salomon, Jacqueline Lehmann‐Che, et al.. (2009). High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors. Cancer Research. 69(2). 663–671. 112 indexed citations

Hupé, Philippe, Ingrid Lebigot, Charles Decraene, et al.. (2009). Genomic Profiling and Identification of High-Risk Uveal Melanoma by Array CGH Analysis of Primary Tumors and Liver Metastases. Investigative Ophthalmology & Visual Science. 50(6). 2572–2572. 90 indexed citations

Maire, Virginie, Eléonore Gravier, Guillem Rigaill, et al.. (2008). Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Breast Cancer Research. 10(6). R101–R101. 170 indexed citations

Bollet, Marc A., Nicolas Servant, Pierre Neuvial, et al.. (2007). High-Resolution Mapping of DNA Breakpoints to Define True Recurrences Among Ipsilateral Breast Cancers. JNCI Journal of the National Cancer Institute. 100(1). 48–58. 44 indexed citations

Crémoux, Patricia de, Martine Thioux, Ingrid Lebigot, et al.. (2007). No evidence of Human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Research and Treatment. 109(1). 55–58. 76 indexed citations

Lebigot, Ingrid, et al.. (2004). Erythroblast Transformation by FLI-1 Depends upon Its Specific DNA Binding and Transcriptional Activation Properties. Journal of Biological Chemistry. 279(4). 2993–3002. 10 indexed citations

Lebigot, Ingrid, et al.. (2003). Up-regulation of SLAP in FLI-1-transformed erythroblasts interferes with EpoR signaling. Blood. 102(13). 4555–4562. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact